OSX2:XETRA:XETRA-Ossiam US Minimum Variance ESG NR UCITS ETF 1A (EUR) EUR (EUR)

ETF | Others |

Last Closing

USD 271.1

Change

-2.05 (-0.75)%

Market Cap

USD 0.12B

Volume

59.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.29 (+0.58%)

USD 450.46B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.08 (+0.51%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.27 (+1.02%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.05 (+0.17%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.16 (+0.66%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

+1.60 (+1.05%)

USD 126.93B
8R80:XETRA Amundi Index Solutions - Amund..

+0.58 (+0.42%)

USD 104.09B
JARI:XETRA Amundi Index Solutions - Amund..

+0.30 (+0.70%)

USD 101.29B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.28 (+0.55%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.54 (-0.11%)

USD 80.38B

ETFs Containing OSX2:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.37% 78% C+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.37% 78% C+ 77% C+
Trailing 12 Months  
Capital Gain 7.49% 55% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.49% 55% F 57% F
Trailing 5 Years  
Capital Gain 44.11% 68% D+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.11% 67% D+ 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 6.12% 61% D- 60% D-
Dividend Return 6.12% 60% D- 57% F
Total Return N/A 66% D+ 78% C+
Risk Return Profile  
Volatility (Standard Deviation) 9.87% 62% D 70% C-
Risk Adjusted Return 61.94% 82% B 83% B
Market Capitalization 0.12B 37% F 34% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.